Citius Oncology Inc [NASDAQ: CTOR] gained 20769152% on the last trading session, reaching $1840000.0 price per share at the time.
Citius Oncology Inc represents 71.55 million in outstanding shares, while the company has a total market value of $188.18 million with the latest information. CTOR stock price has been found in the range of $1.57 to $3.43.
If compared to the average trading volume of 1.84M shares, CTOR reached a trading volume of 20769152 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Citius Oncology Inc [CTOR]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CTOR shares is $3.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CTOR stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Citius Oncology Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 27, 2024.
The Price to Book ratio for the last quarter was 5.28, with the Price to Cash per share for the same quarter was set at 0.00.
Trading performance analysis for CTOR stock
Citius Oncology Inc [CTOR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 78.91. With this latest performance, CTOR shares gained by 195.51% in over the last four-week period, additionally plugging by 139.09% over the last 6 months – not to mention a rise of 128.70% in the past year of trading.
An analysis of Institutional ownership at Citius Oncology Inc [CTOR]
There are presently around $0.76%, or 15.38%% of CTOR stock, in the hands of institutional investors.
